Skip to content
Cardiac Dimensions® Announces Launch of Its Optimized U.S. Pivotal Trial – The EMPOWER Trial
Cardiac Dimensions Announces Two New Meta-Analysis Publications Showing Statistically Significant and Clinically Meaningful Benefits to Heart Failure Patients Suffering from Functional Mitral Regurgitation
Cardiac Dimensions Welcomes Robert White to its Board of Directors
Register for an upcoming seminar.
RESERVE MY SEAT